SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-025638
Filing Date
2017-05-09
Accepted
2017-05-09 16:24:53
Documents
41
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v465639_10q.htm 10-Q 288978
2 EXHIBIT 31.1 v465639_ex31-1.htm EX-31.1 8488
3 EXHIBIT 31.2 v465639_ex31-2.htm EX-31.2 8080
4 EXHIBIT 32.1 v465639_ex32-1.htm EX-32.1 4488
5 EXHIBIT 32.2 v465639_ex32-2.htm EX-32.2 4476
  Complete submission text file 0001144204-17-025638.txt   1667908

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20170331.xml EX-101.INS 238985
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20170331.xsd EX-101.SCH 21230
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20170331_cal.xml EX-101.CAL 18846
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20170331_def.xml EX-101.DEF 117321
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20170331_lab.xml EX-101.LAB 153987
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20170331_pre.xml EX-101.PRE 137014
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 17826774
SIC: 2836 Biological Products, (No Diagnostic Substances)